Profound Medical (PROF) Non-Current Receivables (2018 - 2024)
Profound Medical's quarterly Non-Current Receivables came in at $310000.0 in Q3 2024, up 300.0% year-on-year from $77500.0 in Q4 2023, and down 35.95% quarter-over-quarter from $484000.0 in Q2 2024.
Profound Medical has reported Non-Current Receivables for 7 years, with the latest figure at $310000.0 in Q3 2024.
- For the quarter ending Q3 2024, Non-Current Receivables rose 300.0% year-over-year to $310000.0; the trailing twelve-month figure through Sep 2024 stood at $310000.0 (up 300.0% YoY), and the FY2023 full-year result was $7.3 million, up 14.88% from the prior year.
- Non-Current Receivables for Q3 2024 stood at $310000.0, down from $484000.0 in the prior quarter.
- The five-year high for Non-Current Receivables was $8.0 million in Q3 2021, with the low at -$600000.0 in Q1 2023.
- Average Non-Current Receivables over 5 years is $2.4 million, with a median of $1.1 million recorded in 2021.
- Year-over-year, Non-Current Receivables jumped 63444.05% in 2021 and sank 133.52% in 2022.
- Tracing PROF's Non-Current Receivables over 5 years: stood at $5700.0 in 2020, then jumped by 63444.05% to $3.6 million in 2021, then jumped by 75.15% to $6.3 million in 2022, then rose by 14.88% to $7.3 million in 2023, then tumbled by 95.75% to $310000.0 in 2024.
- The last three Non-Current Receivables figures came in at $310000.0 (Q3 2024), $484000.0 (Q2 2024), and $6.5 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 257.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 310,000.00 |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | 6.51 Mn |
| Dec 31, 2023 | 7.29 Mn |
| Sep 30, 2023 | -155,000.00 |
| Jun 30, 2023 | 6.59 Mn |
| Mar 31, 2023 | -600,000.00 |
| Dec 31, 2022 | 6.34 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 823,000.00 |
| Mar 31, 2022 | -365,000.00 |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 7.95 Mn |
| Jun 30, 2021 | 56,000.00 |
| Mar 31, 2021 | 1.09 Mn |
| Dec 31, 2020 | 5,699.98 |
| Sep 30, 2020 | 1.50 Mn |
| Jun 30, 2020 | 3.37 Mn |
| Mar 31, 2020 | -307,000.00 |
| Dec 31, 2019 | 3.07 Mn |
| Sep 30, 2019 | 1.47 Mn |
| Jun 30, 2019 | -185,483.35 |
| Mar 31, 2019 | -271,123.00 |
| Dec 31, 2018 | 2.69 Mn |